FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 592 participants.
Also called NCT03490201
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 592 participants
- Sponsor
- Registry
-
NCT03490201
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Australia, Czechia, France, Germany, Italy, Spain, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT03490201. Randomized; single masking; primary purpose treatment. Start 2018-06-01 (actual); primary completion 2024-04-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study
- Acronym
- LESS-VT
- Condition
- Ventricular Tachycardia
- Intervention (Device)
- Market Approved RF Ablation System
- Intervention (Device)
- FlexAbility SE Ablation Catheter
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct03490201- Content hash
a360bd3a55b5b42de584a3aea3f3c8eb09c725b9c323effdb72c150f1aceb94a